A pharmaceutical company in the United States submitted its patented product proposal for instant nicotine flakes to the National Science Foundation (NSF) and passed the first round of screening. The company expects to receive a response by the end of April and, if funded, will be used for extensive research and testing.
According to Accessnewswire on February 12, the US Pharmaceutical company CTT Pharmaceutical Holdings, Inc. Submitted a full proposal for its patented instant nicotine flakes to the National Science Foundation (NSF).
Research on Instant Nicotine Flakes Helped
CTT made it through the first round of screening, where the company and other finalists are required to submit full funding proposals by multiple deadlines over a year. CTT expects to receive a response on the project by the end of April. If accepted, CTT Pharma will receive government funding to conduct extensive research and testing.
Ryan Khouri, CEO of CTT, said,
- “Getting past the first round of applications is a tremendous achievement in itself and shows that NSF sees the potential value of our technology in the tobacco industry.” There are currently no instant, low-dose nicotine flakes on the market because most oral products stay in the mouth for too long. CTT has also invited a person with extensive experience in NSF grants to join our team to help advance this NSF grant application.”
